. (ARIA)

$23.99 0 (0.00%)

Market Cap: $0

As of 07/22/19 12:00 AM EDT. Market closed.

(ARIA)

. (ARIA)

$23.99 0 (0.00%)

Market Cap: $0

As of 07/22/19 12:00 AM EDT. Market closed.

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$23.99
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$23.99
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Cole Hugh M SVP, Chief Business Officer Jun 25, 2015 Option Exercise $8.69 6,249 54,304 42,834 Feb 07, 2017, 04:59 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jan 31, 2017 Option Exercise $23.81 14,667 349,293 126,352 Feb 02, 2017, 04:42 PM
CLACKSON TIMOTHY P President, R&D, CSO Jan 31, 2017 Option Exercise $23.82 9,610 228,886 219,867 Feb 02, 2017, 04:41 PM
Panayiotopoulos Paris President and CEO Jan 17, 2017 Option Exercise $23.69 33,300 788,934 159,378 Jan 17, 2017, 05:06 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jan 09, 2017 Option Exercise $7.82 32,000 250,240 161,404 Jan 10, 2017, 06:17 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jan 09, 2017 Sale $23.78 32,000 760,960 129,404 Jan 10, 2017, 06:17 PM
CLACKSON TIMOTHY P President, R&D, CSO Oct 24, 2016 Sale $9.56 19,638 187,739 197,884 Oct 25, 2016, 04:07 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Oct 03, 2016 Sale $13.46 47,384 637,812 129,404 Oct 05, 2016, 04:17 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 28, 2016 Sale $13.98 8,750 122,311 217,522 Sep 28, 2016, 04:19 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 22, 2016 Sale $13.43 20,000 268,536 208,772 Sep 23, 2016, 05:46 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 15, 2016 Option Exercise $7.82 59,369 464,266 288,141 Sep 16, 2016, 05:08 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 15, 2016 Sale $11.73 59,369 696,398 228,772 Sep 16, 2016, 05:08 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 22, 2016 Sale $10.47 19,436 203,538 228,772 Aug 23, 2016, 04:12 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 12, 2016 Option Exercise $7.69 25,000 192,250 273,208 Aug 15, 2016, 04:16 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 12, 2016 Sale $10.50 25,000 262,500 248,208 Aug 15, 2016, 04:16 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 22, 2016 Sale $8.11 18,286 148,230 248,208 Jul 25, 2016, 04:39 PM
Panayiotopoulos Paris President and CEO Jul 13, 2016 Option Exercise $7.14 28,611 204,283 126,078 Jul 14, 2016, 04:23 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 01, 2016 Option Exercise $3.88 61,422 238,585 297,916 Jul 05, 2016, 04:07 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 01, 2016 Sale $7.48 61,422 459,634 266,494 Jul 05, 2016, 04:07 PM
Cole Hugh M SVP, Chief Business Officer Jun 28, 2016 Sale $7.05 6,012 42,385 29,916 Jun 29, 2016, 04:25 PM
CLACKSON TIMOTHY P President, R&D, CSO Jun 22, 2016 Sale $7.28 23,999 174,638 264,742 Jun 23, 2016, 04:11 PM
LAVIDAS ATHANESE Director Jun 13, 2016 Option Exercise $5.49 10,000 54,900 141,631 Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESE Director Jun 15, 2016 Option Exercise $6.55 46,250 302,787 177,881 Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESE Director Jun 14, 2016 Option Exercise $6.44 20,000 128,800 151,631 Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESE Director Jun 13, 2016 Sale $8.20 10,000 82,050 131,631 Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESE Director Jun 15, 2016 Sale $8.24 46,250 381,137 131,631 Jun 15, 2016, 04:19 PM
LAVIDAS ATHANESE Director Jun 14, 2016 Sale $8.14 20,000 162,852 131,631 Jun 15, 2016, 04:19 PM
Radaelli Massimo Director Jun 13, 2016 Option Exercise $6.57 79,731 523,551 185,231 Jun 14, 2016, 06:13 PM
Radaelli Massimo Director Jun 10, 2016 Option Exercise $1.35 22,588 30,494 128,088 Jun 14, 2016, 06:13 PM
Radaelli Massimo Director Jun 14, 2016 Option Exercise $4.91 6,250 30,687 111,750 Jun 14, 2016, 06:13 PM
Radaelli Massimo Director Jun 10, 2016 Sale $8.30 22,588 187,480 105,500 Jun 14, 2016, 06:13 PM
Radaelli Massimo Director Jun 14, 2016 Sale $8.13 6,250 50,834 105,500 Jun 14, 2016, 06:13 PM
Radaelli Massimo Director Jun 13, 2016 Sale $8.25 79,731 657,821 105,500 Jun 14, 2016, 06:13 PM
CLACKSON TIMOTHY P President, R&D, CSO May 23, 2016 Sale $8.08 17,762 143,430 288,741 May 25, 2016, 04:04 PM
Panayiotopoulos Paris President and CEO May 12, 2016 Buy $7.41 26,990 199,996 88,089 May 13, 2016, 05:59 PM
Haluska Frank SVP, Clinical R&D, CMO Apr 29, 2016 Option Exercise $7.18 5,634 40,452 158,711 May 02, 2016, 05:33 PM
Cantor Maria E SVP, Corporate Affairs Apr 29, 2016 Option Exercise $7.18 4,334 31,118 144,667 May 02, 2016, 05:32 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Apr 29, 2016 Option Exercise $7.18 5,634 40,452 166,788 May 02, 2016, 05:30 PM
Cole Hugh M SVP, Chief Business Officer Apr 29, 2016 Option Exercise $7.18 5,634 40,452 16,762 May 02, 2016, 05:29 PM
CLACKSON TIMOTHY P President, R&D, CSO May 02, 2016 Sale $7.13 11,700 83,478 306,503 May 02, 2016, 05:28 PM
Duvall Martin J EVP, CCO Apr 29, 2016 Option Exercise $7.18 5,850 42,003 105,189 May 02, 2016, 05:26 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 22, 2016 Sale $7.37 21,409 157,864 294,803 Apr 25, 2016, 04:04 PM
DesRosier Thomas EVP, General Counsel Feb 18, 2016 Option Exercise $5.03 18,370 92,401 36,630 Mar 30, 2016, 05:04 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 22, 2016 Sale $6.58 23,834 156,871 316,212 Mar 23, 2016, 04:41 PM
Duvall Martin J EVP, CCO Mar 19, 2016 Sale $6.47 4,000 25,867 93,039 Mar 22, 2016, 04:03 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 21, 2016 Sale $6.47 2,375 15,356 262,115 Mar 22, 2016, 04:02 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 21, 2016 Sale $6.47 4,000 25,871 155,088 Mar 22, 2016, 04:02 PM
Cantor Maria E SVP, Corporate Affairs Mar 19, 2016 Sale $6.46 3,575 23,102 135,667 Mar 22, 2016, 04:02 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 19, 2016 Sale $6.47 5,417 35,039 340,046 Mar 22, 2016, 04:01 PM
FITZGERALD EDWARD M Executive VP Mar 21, 2016 Sale $6.47 5,417 35,037 320,367 Mar 22, 2016, 04:01 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 21, 2016 Sale $6.47 3,575 23,116 147,011 Mar 22, 2016, 04:01 PM
Cole Hugh M SVP, Chief Business Officer Mar 16, 2016 Option Exercise $6.21 2,438 15,140 5,062 Mar 18, 2016, 04:04 PM
Cole Hugh M SVP, Chief Business Officer Mar 16, 2016 Option Exercise $6.21 7,500 46,575 7,500 Mar 18, 2016, 04:04 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 15, 2016 Option Exercise $6.18 22,814 141,009 132,024 Mar 17, 2016, 04:45 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 15, 2016 Option Exercise $1.30 3,750 4,875 154,838 Mar 17, 2016, 04:45 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 03, 2016 Sale $6.12 9,625 58,866 314,951 Mar 03, 2016, 08:12 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 03, 2016 Sale $6.12 9,625 58,887 259,740 Mar 03, 2016, 08:08 PM
Duvall Martin J EVP, CCO Mar 03, 2016 Sale $6.12 9,625 58,863 89,039 Mar 03, 2016, 08:07 PM
Cantor Maria E SVP, Corporate Affairs Mar 03, 2016 Sale $6.12 9,625 58,869 132,742 Mar 03, 2016, 08:00 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 03, 2016 Sale $6.12 9,625 58,867 334,630 Mar 03, 2016, 08:00 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 02, 2016 Sale $6.00 25,047 150,282 344,255 Mar 03, 2016, 08:00 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 03, 2016 Sale $6.11 9,625 58,852 151,088 Mar 03, 2016, 07:59 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 03, 2016 Sale $6.11 10,588 64,733 144,086 Mar 03, 2016, 07:58 PM
Panayiotopoulos Paris President and CEO Feb 01, 2016 Buy $4.91 61,099 299,996 61,099 Feb 03, 2016, 05:43 PM
Duvall Martin J EVP, CCO Feb 01, 2016 Sale $4.81 14,667 70,578 79,414 Feb 03, 2016, 04:46 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 01, 2016 Sale $4.81 14,667 70,517 350,052 Feb 03, 2016, 04:43 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Feb 01, 2016 Sale $4.81 14,667 70,548 141,463 Feb 03, 2016, 04:41 PM
Haluska Frank SVP, Clinical R&D, CMO Feb 01, 2016 Sale $4.81 16,133 77,587 135,424 Feb 03, 2016, 04:39 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Feb 01, 2016 Sale $4.81 14,667 70,515 250,115 Feb 03, 2016, 04:38 PM
FITZGERALD EDWARD M Executive VP, CFO Feb 01, 2016 Sale $4.81 14,667 70,515 305,326 Feb 03, 2016, 04:37 PM
Cantor Maria E SVP, Corporate Affairs Feb 01, 2016 Sale $4.82 16,133 77,745 137,784 Feb 03, 2016, 04:35 PM
BERGER HARVEY J M D Chairman & CEO Dec 31, 2015 Option Exercise $6.25 284,381 1,777,381 1,732,111 Jan 05, 2016, 05:41 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Sep 28, 2015 Sale $6.46 5,000 32,315 235,449 Sep 30, 2015, 04:14 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 28, 2015 Sale $6.46 5,000 32,315 126,797 Sep 28, 2015, 06:35 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 28, 2015 Sale $6.46 5,000 32,315 126,797 Sep 28, 2015, 06:14 PM
Duvall Martin J EVP, CCO Sep 28, 2015 Sale $6.46 5,000 32,317 64,748 Sep 28, 2015, 06:09 PM
Cantor Maria E SVP, Corporate Affairs Sep 28, 2015 Sale $6.47 5,000 32,327 109,917 Sep 28, 2015, 05:57 PM
FITZGERALD EDWARD M Executive VP, CFO Sep 28, 2015 Sale $6.46 8,750 56,551 289,231 Sep 28, 2015, 05:50 PM
Haluska Frank SVP, Clinical R&D, CMO Sep 28, 2015 Sale $6.45 5,500 35,502 122,224 Sep 28, 2015, 05:40 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 28, 2015 Sale $6.46 8,750 56,560 334,086 Sep 28, 2015, 05:36 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Sep 28, 2015 Sale $6.46 5,000 32,315 240,449 Sep 28, 2015, 05:02 PM
Cantor Maria E SVP, Corporate Affairs Sep 01, 2015 Sale $9.11 2,696 24,557 104,917 Sep 03, 2015, 04:20 PM
FITZGERALD EDWARD M Executive VP, CFO Aug 28, 2015 Sale $10.00 32,858 328,580 280,481 Sep 01, 2015, 05:14 PM
Cantor Maria E SVP, Corporate Affairs Aug 28, 2015 Sale $10.00 1,268 12,680 107,613 Sep 01, 2015, 05:14 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 16, 2015 Sale $8.54 7,000 59,797 325,336 Jul 16, 2015, 05:40 PM
Duvall Martin J EVP, CCO Jul 16, 2015 Sale $8.54 1,400 11,956 59,748 Jul 16, 2015, 05:34 PM
FITZGERALD EDWARD M Executive VP, CFO Jul 16, 2015 Sale $8.54 7,000 59,793 313,339 Jul 16, 2015, 05:25 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jul 16, 2015 Sale $8.54 4,000 34,164 121,797 Jul 16, 2015, 05:14 PM
Cantor Maria E SVP, Corporate Affairs Jul 16, 2015 Sale $8.54 4,000 34,162 108,881 Jul 16, 2015, 05:12 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Jul 16, 2015 Sale $8.54 4,000 34,162 230,449 Jul 16, 2015, 05:10 PM
Haluska Frank SVP, Clinical R&D, CMO Jul 16, 2015 Sale $8.54 4,400 37,575 117,724 Jul 16, 2015, 05:08 PM
BERGER HARVEY J M D Chairman & CEO Jul 15, 2015 Option Exercise $8.35 17,370 145,040 1,366,492 Jul 16, 2015, 04:22 PM
FITZGERALD EDWARD M Executive VP, CFO May 01, 2015 Option Exercise $7.56 60,000 453,600 365,852 May 04, 2015, 04:36 PM
FITZGERALD EDWARD M Executive VP, CFO May 01, 2015 Sale $8.80 60,000 528,000 305,852 May 04, 2015, 04:36 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 23, 2015 Sale $9.50 123,766 1,175,777 316,548 Apr 27, 2015, 04:14 PM
BERGER HARVEY J M D Chairman & CEO Mar 26, 2015 Option Exercise $8.17 127,194 1,039,175 1,343,460 Mar 30, 2015, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Mar 26, 2015 Option Exercise $7.56 150,000 1,134,000 1,446,175 Mar 30, 2015, 04:21 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 20, 2015 Sale $8.85 2,375 21,026 224,449 Mar 23, 2015, 06:26 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 23, 2015 Sale $8.56 2,000 17,118 226,449 Mar 23, 2015, 06:26 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 19, 2015 Option Exercise $3.08 7,875 24,255 114,504 Mar 23, 2015, 06:16 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 23, 2015 Sale $8.55 4,033 34,491 104,881 Mar 23, 2015, 06:16 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 20, 2015 Sale $8.85 3,575 31,627 101,583 Mar 23, 2015, 06:16 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 19, 2015 Sale $9.00 9,346 84,114 106,629 Mar 23, 2015, 06:16 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 20, 2015 Sale $8.85 4,000 35,390 114,797 Mar 23, 2015, 06:06 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 23, 2015 Sale $8.55 3,000 25,661 117,797 Mar 23, 2015, 06:06 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 23, 2015 Sale $8.55 4,167 35,630 305,209 Mar 23, 2015, 06:02 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 20, 2015 Sale $8.84 5,417 47,908 301,043 Mar 23, 2015, 06:02 PM
Duvall Martin J EVP, CCO Mar 23, 2015 Sale $8.57 834 7,145 54,950 Mar 23, 2015, 05:59 PM
Duvall Martin J EVP, CCO Mar 20, 2015 Sale $8.85 4,000 35,381 54,117 Mar 23, 2015, 05:59 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 20, 2015 Sale $8.85 3,575 31,634 111,424 Mar 23, 2015, 05:54 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 23, 2015 Sale $8.55 3,300 28,229 114,124 Mar 23, 2015, 05:54 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 19, 2015 Option Exercise $7.56 20,657 156,167 460,971 Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 23, 2015 Sale $8.55 6,667 57,016 440,314 Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 20, 2015 Sale $8.84 5,417 47,910 433,648 Mar 23, 2015, 05:45 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 19, 2015 Sale $9.00 20,657 185,913 440,314 Mar 23, 2015, 05:45 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 20, 2015 Sale $8.85 2,375 21,026 157,907 Mar 23, 2015, 05:27 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Mar 23, 2015 Sale $8.56 2,000 17,118 159,907 Mar 23, 2015, 05:27 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 16, 2015 Option Exercise $1.30 7,500 9,750 145,222 Mar 18, 2015, 04:23 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 16, 2015 Sale $8.62 34,425 296,651 137,722 Mar 18, 2015, 04:23 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 20, 2015 Option Exercise $3.54 49,035 173,419 453,231 Feb 24, 2015, 04:23 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 20, 2015 Sale $8.00 49,035 392,280 428,232 Feb 24, 2015, 04:23 PM
BERGER HARVEY J M D Chairman & CEO Feb 11, 2015 Buy $6.77 12,500 84,569 1,851,786 Feb 13, 2015, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Feb 12, 2015 Buy $6.90 12,500 86,280 1,864,286 Feb 13, 2015, 04:21 PM
Haluska Frank SVP, Clinical R&D, CMO Feb 02, 2015 Sale $6.33 16,134 102,107 108,499 Feb 04, 2015, 04:52 PM
Cantor Maria E SVP, Corporate Affairs and HR Feb 02, 2015 Sale $6.33 16,134 102,089 100,129 Feb 04, 2015, 04:19 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Feb 02, 2015 Sale $6.33 14,667 92,823 137,722 Feb 04, 2015, 04:18 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 02, 2015 Sale $6.33 14,667 92,820 428,232 Feb 04, 2015, 04:17 PM
Duvall Martin J EVP, CCO Feb 02, 2015 Sale $6.33 14,667 92,823 50,117 Feb 04, 2015, 04:16 PM
FITZGERALD EDWARD M Executive VP, CFO Feb 02, 2015 Sale $6.33 14,667 92,849 295,627 Feb 04, 2015, 04:16 PM
BERSTEIN DAVID L SVP, Chief IP Counsel Feb 02, 2015 Sale $6.33 14,667 92,826 222,074 Feb 04, 2015, 04:14 PM
BERGER HARVEY J M D Chairman & CEO Jan 23, 2015 Buy $6.18 12,500 77,250 1,839,286 Jan 26, 2015, 04:09 PM
BERGER HARVEY J M D Chairman & CEO Jan 22, 2015 Buy $6.16 12,500 76,990 1,826,786 Jan 26, 2015, 04:09 PM
Schlesinger Sarah J. Director Jan 14, 2015 Buy $6.25 1,300 8,125 15,600 Jan 15, 2015, 04:30 PM
Schlesinger Sarah J. Director Jan 13, 2015 Buy $6.97 1,300 9,061 14,300 Jan 15, 2015, 04:30 PM
BERGER HARVEY J M D Chairman & CEO Dec 18, 2014 Buy $6.54 12,500 81,770 1,814,286 Dec 19, 2014, 04:29 PM
BERGER HARVEY J M D Chairman & CEO Dec 17, 2014 Buy $6.15 12,500 76,875 1,801,786 Dec 19, 2014, 04:29 PM
Schlesinger Sarah J. Director Dec 17, 2014 Buy $6.11 1,300 7,943 13,000 Dec 18, 2014, 04:09 PM
Schlesinger Sarah J. Director Dec 16, 2014 Buy $6.07 1,300 7,891 11,700 Dec 18, 2014, 04:09 PM
Cantor Maria E SVP, Corporate Affairs and HR Nov 24, 2014 Sale $7.00 1,749 12,243 86,929 Nov 25, 2014, 04:22 PM
BERGER HARVEY J M D Chairman & CEO Nov 20, 2014 Buy $6.15 12,500 76,889 1,789,286 Nov 21, 2014, 04:18 PM
BERGER HARVEY J M D Chairman & CEO Nov 19, 2014 Buy $6.15 12,500 76,853 1,776,786 Nov 21, 2014, 04:18 PM
Schlesinger Sarah J. Director Nov 12, 2014 Buy $6.22 1,300 8,086 10,400 Nov 13, 2014, 04:27 PM
Schlesinger Sarah J. Director Nov 11, 2014 Buy $6.30 1,300 8,190 9,100 Nov 13, 2014, 04:27 PM
BERGER HARVEY J M D Chairman & CEO Oct 16, 2014 Buy $5.39 12,500 67,317 1,764,286 Oct 17, 2014, 04:24 PM
BERGER HARVEY J M D Chairman & CEO Oct 15, 2014 Buy $5.10 12,500 63,727 1,751,786 Oct 17, 2014, 04:24 PM
Schlesinger Sarah J. Director Oct 15, 2014 Buy $5.03 1,300 6,539 7,800 Oct 16, 2014, 04:27 PM
Schlesinger Sarah J. Director Oct 14, 2014 Buy $5.07 1,300 6,591 6,500 Oct 16, 2014, 04:27 PM
BERGER HARVEY J M D Chairman & CEO Sep 03, 2014 Buy $6.31 12,500 78,859 1,739,286 Sep 18, 2014, 04:30 PM
BERGER HARVEY J M D Chairman & CEO Sep 02, 2014 Buy $6.22 12,500 77,777 1,726,786 Sep 18, 2014, 04:30 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Sep 09, 2014 Option Exercise $5.75 7,118 40,929 236,741 Sep 11, 2014, 04:41 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Sep 09, 2014 Option Exercise $5.23 7,825 40,925 147,983 Sep 11, 2014, 04:41 PM
BERGER HARVEY J M D Chairman & CEO Sep 09, 2014 Option Exercise $5.75 124,613 716,525 1,163,564 Sep 11, 2014, 04:39 PM
BERGER HARVEY J M D Chairman & CEO Sep 09, 2014 Option Exercise $5.23 150,000 784,500 1,294,277 Sep 11, 2014, 04:39 PM
BERGER HARVEY J M D Chairman & CEO Sep 03, 2014 Buy $6.31 12,500 78,859 1,739,286 Sep 11, 2014, 04:39 PM
BERGER HARVEY J M D Chairman & CEO Sep 02, 2014 Buy $6.22 12,500 77,777 1,726,786 Sep 11, 2014, 04:39 PM
Schlesinger Sarah J. Director Aug 12, 2014 Buy $5.52 1,300 7,176 1,300 Sep 11, 2014, 04:38 PM
Schlesinger Sarah J. Director Sep 10, 2014 Buy $5.75 1,300 7,475 5,200 Sep 11, 2014, 04:38 PM
Schlesinger Sarah J. Director Sep 09, 2014 Buy $5.93 1,300 7,709 3,900 Sep 11, 2014, 04:38 PM
Schlesinger Sarah J. Director Aug 13, 2014 Buy $5.71 1,300 7,423 2,600 Sep 11, 2014, 04:38 PM
FITZGERALD EDWARD M Executive VP, CFO Sep 02, 2014 Option Exercise $5.23 50,000 261,500 305,960 Sep 04, 2014, 04:24 PM
FITZGERALD EDWARD M Executive VP, CFO Sep 02, 2014 Sale $6.22 50,000 310,835 280,960 Sep 04, 2014, 04:24 PM
Cantor Maria E SVP, Corporate Affairs and HR Sep 02, 2014 Sale $6.21 2,696 16,753 88,678 Sep 04, 2014, 04:22 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 02, 2014 Option Exercise $1.30 26,250 34,125 179,705 Sep 04, 2014, 04:21 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 02, 2014 Sale $6.22 56,650 352,227 153,455 Sep 04, 2014, 04:21 PM
DENNER ALEXANDER J Director Aug 15, 2014 Buy $5.83 615,466 3,588,167 7,798,665 Aug 19, 2014, 06:04 PM
DENNER ALEXANDER J Director Aug 15, 2014 Buy $5.83 234,534 1,367,333 5,051,335 Aug 19, 2014, 06:04 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Jul 15, 2014 Option Exercise $5.57 2,608 14,527 236,034 Jul 17, 2014, 05:04 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jul 15, 2014 Option Exercise $5.57 2,608 14,527 153,455 Jul 17, 2014, 05:03 PM
Cantor Maria E SVP, Corporate Affairs and HR Jul 15, 2014 Option Exercise $5.57 2,608 14,527 91,374 Jul 17, 2014, 05:02 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 15, 2014 Option Exercise $5.57 4,564 25,421 413,565 Jul 17, 2014, 05:02 PM
Haluska Frank SVP, Clinical R&D, CMO Jul 15, 2014 Option Exercise $5.57 2,608 14,527 95,299 Jul 17, 2014, 05:01 PM
FITZGERALD EDWARD M Executive VP, CFO Jul 15, 2014 Option Exercise $5.57 4,564 25,421 280,960 Jul 17, 2014, 05:00 PM
BERGER HARVEY J M D Chairman & CEO Jul 15, 2014 Option Exercise $5.57 15,556 86,647 1,122,621 Jul 17, 2014, 04:59 PM
Duvall Martin J EVP, CCO Jul 15, 2014 Option Exercise $5.57 913 5,085 35,450 Jul 17, 2014, 04:58 PM
Cantor Maria E SVP, Corporate Affairs and HR Jun 02, 2014 Sale $6.90 3,713 25,611 84,461 Jun 04, 2014, 04:29 PM
Haluska Frank SVP, Clinical R&D, CMO Apr 02, 2014 Sale $8.21 3,400 27,916 104,296 Apr 03, 2014, 04:32 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Apr 02, 2014 Sale $8.22 2,400 19,718 230,642 Apr 03, 2014, 04:31 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Apr 02, 2014 Sale $8.22 2,400 19,720 148,063 Apr 03, 2014, 04:30 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 01, 2014 Option Exercise $8.52 4,238 36,108 270,928 Apr 03, 2014, 04:29 PM
BERGER HARVEY J M D Chairman & CEO Apr 01, 2014 Option Exercise $8.52 13,584 115,736 1,129,324 Apr 03, 2014, 04:28 PM
Cantor Maria E SVP, Corporate Affairs and HR Apr 02, 2014 Sale $8.21 4,250 34,907 88,174 Apr 03, 2014, 04:28 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 02, 2014 Sale $8.21 6,500 53,337 403,028 Apr 03, 2014, 04:27 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 19, 2014 Option Exercise $8.19 2,061 16,880 78,713 Mar 21, 2014, 05:30 PM
Cantor Maria E SVP, Corporate Affairs and HR Mar 21, 2014 Sale $7.89 3,667 28,930 82,379 Mar 21, 2014, 05:30 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Mar 19, 2014 Option Exercise $8.19 1,506 12,334 224,642 Mar 21, 2014, 05:28 PM
BERSTEIN DAVID L SVP, GC and Chief IP Officer Mar 21, 2014 Sale $7.89 1,600 12,630 227,042 Mar 21, 2014, 05:28 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 19, 2014 Option Exercise $8.19 2,061 16,880 95,596 Mar 21, 2014, 05:28 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 21, 2014 Sale $7.89 2,400 18,941 99,196 Mar 21, 2014, 05:28 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 19, 2014 Option Exercise $8.19 2,536 20,770 140,863 Mar 21, 2014, 05:21 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 21, 2014 Sale $7.89 2,400 18,936 144,463 Mar 21, 2014, 05:21 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 19, 2014 Option Exercise $8.19 3,442 28,190 387,711 Mar 21, 2014, 05:20 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 21, 2014 Sale $7.89 6,667 52,583 394,377 Mar 21, 2014, 05:20 PM
Duvall Martin J EVP, CCO Mar 20, 2014 Option Exercise $8.13 529 4,301 30,340 Mar 21, 2014, 04:11 PM
Duvall Martin J EVP, CCO Mar 19, 2014 Option Exercise $8.19 2,618 21,441 29,203 Mar 21, 2014, 04:11 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 20, 2014 Option Exercise $8.13 2,717 22,089 261,556 Mar 21, 2014, 04:10 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 19, 2014 Option Exercise $8.19 3,435 28,133 255,940 Mar 21, 2014, 04:10 PM
BERGER HARVEY J M D Chairman & CEO Mar 20, 2014 Option Exercise $8.13 11,084 90,113 1,097,964 Mar 21, 2014, 04:09 PM
BERGER HARVEY J M D Chairman & CEO Mar 19, 2014 Option Exercise $8.19 11,711 95,913 1,075,048 Mar 21, 2014, 04:09 PM
CLACKSON TIMOTHY P President, R&D, CSO Dec 19, 2013 Sale $5.14 9,750 50,115 380,319 Dec 20, 2013, 04:39 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Dec 19, 2013 Sale $5.15 3,600 18,528 135,399 Dec 20, 2013, 04:38 PM
Cantor Maria E SVP, Corporate Affairs Dec 19, 2013 Sale $5.14 6,375 32,767 74,274 Dec 20, 2013, 04:35 PM
BERGER HARVEY J M D Chairman & CEO Dec 18, 2013 Option Exercise $4.98 29,500 146,910 1,050,759 Dec 20, 2013, 04:33 PM
Haluska Frank SVP, Clinical R&D, CMO Dec 19, 2013 Sale $5.14 5,100 26,214 91,157 Dec 20, 2013, 04:33 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Dec 19, 2013 Sale $5.14 4,500 23,130 221,398 Dec 20, 2013, 04:31 PM
Duvall Martin J SVP, Commercial Operations Sep 19, 2013 Option Exercise $21.49 10,918 234,628 23,821 Sep 24, 2013, 04:03 PM
CLACKSON TIMOTHY P President, R&D, CSO Sep 06, 2013 Sale $22.00 8,449 185,878 370,451 Sep 10, 2013, 04:32 PM
FITZGERALD EDWARD M Executive VP, CFO Aug 15, 2013 Option Exercise $18.11 19,342 350,284 228,243 Aug 16, 2013, 04:23 PM
FITZGERALD EDWARD M Executive VP, CFO Aug 15, 2013 Option Exercise $3.90 33,000 128,700 247,585 Aug 16, 2013, 04:23 PM
BERGER HARVEY J M D Chairman & CEO Aug 14, 2013 Sale $18.37 3,157 57,999 0 Aug 15, 2013, 04:26 PM
BERGER HARVEY J M D Chairman & CEO Aug 14, 2013 Sale $18.51 62,902 1,164,335 1,242,759 Aug 15, 2013, 04:26 PM
BERGER HARVEY J M D Chairman & CEO Aug 13, 2013 Sale $18.36 2,700 49,570 3,157 Aug 15, 2013, 04:26 PM
BERGER HARVEY J M D Chairman & CEO Aug 13, 2013 Sale $18.11 50,000 905,555 1,305,661 Aug 15, 2013, 04:26 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jul 18, 2013 Sale $19.79 6,400 126,639 129,978 Jul 18, 2013, 05:53 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Jul 18, 2013 Sale $19.79 8,000 158,290 216,898 Jul 18, 2013, 05:53 PM
Haluska Frank SVP, Clinical R&D, CMO Jul 18, 2013 Sale $19.79 6,400 126,642 83,507 Jul 18, 2013, 05:51 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Jul 18, 2013 Sale $19.79 6,400 126,655 67,282 Jul 18, 2013, 05:50 PM
Keane Raymond T SVP General Counsel & CCO Jul 18, 2013 Sale $19.79 8,000 158,286 62,096 Jul 18, 2013, 05:49 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 18, 2013 Sale $19.79 14,000 277,045 378,900 Jul 18, 2013, 05:47 PM
Cantor Maria E SVP, Corporate Affairs Jul 18, 2013 Sale $19.79 8,000 158,299 67,724 Jul 18, 2013, 05:46 PM
BERGER HARVEY J M D Chairman & CEO Jul 16, 2013 Sale $20.97 2,700 56,623 8,557 Jul 18, 2013, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Jul 16, 2013 Sale $19.91 144,000 2,866,478 1,405,861 Jul 18, 2013, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Jul 17, 2013 Sale $19.60 2,700 52,912 5,857 Jul 18, 2013, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Jul 17, 2013 Sale $19.61 50,000 980,705 1,355,861 Jul 18, 2013, 04:21 PM
BERGER HARVEY J M D Chairman & CEO Jul 15, 2013 Option Exercise $20.98 34,776 729,600 1,549,861 Jul 17, 2013, 04:42 PM
FITZGERALD EDWARD M Executive VP, CFO Jul 15, 2013 Option Exercise $20.98 13,230 277,565 214,585 Jul 17, 2013, 04:38 PM
BERGER HARVEY J M D Chairman & CEO Jun 19, 2013 Sale $18.00 5,400 97,208 11,257 Jun 21, 2013, 04:19 PM
BERGER HARVEY J M D Chairman & CEO Jun 19, 2013 Sale $18.00 5,800 104,415 1,511,037 Jun 21, 2013, 04:19 PM
BERGER HARVEY J M D Chairman & CEO May 15, 2013 Sale $18.14 2,700 48,983 16,657 May 16, 2013, 04:38 PM
BERGER HARVEY J M D Chairman & CEO May 15, 2013 Sale $18.22 37,098 675,970 1,516,837 May 16, 2013, 04:38 PM
BERGER HARVEY J M D Chairman & CEO May 14, 2013 Sale $18.00 2,700 48,600 19,357 May 16, 2013, 04:38 PM
BERGER HARVEY J M D Chairman & CEO May 14, 2013 Sale $18.01 50,000 900,295 1,553,935 May 16, 2013, 04:38 PM
BERGER HARVEY J M D Chairman & CEO Apr 17, 2013 Sale $18.01 100,000 1,800,590 1,667,521 Apr 22, 2013, 05:07 PM
BERGER HARVEY J M D Chairman & CEO Apr 17, 2013 Sale $18.00 5,400 97,201 22,057 Apr 22, 2013, 05:07 PM
Keane Raymond T SVP General Counsel & CCO Apr 02, 2013 Sale $18.05 2,583 46,625 54,096 Apr 03, 2013, 04:58 PM
Haluska Frank SVP, Clinical R&D, CMO Apr 02, 2013 Sale $18.04 3,400 61,339 73,907 Apr 03, 2013, 04:57 PM
Cantor Maria E SVP, Corporate Affairs Apr 02, 2013 Sale $18.04 4,250 76,665 62,275 Apr 03, 2013, 04:55 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 02, 2013 Sale $18.04 6,500 117,245 363,705 Apr 03, 2013, 04:53 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 02, 2013 Sale $18.04 2,400 43,295 57,682 Apr 03, 2013, 04:52 PM
BERGER HARVEY J M D Chairman & CEO Apr 01, 2013 Option Exercise $18.30 19,688 360,290 1,767,521 Apr 03, 2013, 04:51 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Apr 02, 2013 Sale $18.05 2,400 43,322 208,898 Apr 03, 2013, 04:47 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 26, 2013 Sale $18.75 12,933 242,492 191,555 Mar 26, 2013, 04:57 PM
Keane Raymond T SVP General Counsel & CCO Mar 25, 2013 Sale $18.87 13,167 248,482 51,513 Mar 26, 2013, 04:40 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 25, 2013 Sale $18.87 8,133 153,482 54,082 Mar 26, 2013, 04:38 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 25, 2013 Sale $18.87 10,533 198,807 205,298 Mar 26, 2013, 04:36 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 25, 2013 Sale $18.88 5,333 100,672 68,807 Mar 26, 2013, 04:36 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 25, 2013 Sale $18.87 19,167 361,766 357,205 Mar 26, 2013, 04:34 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 25, 2013 Sale $18.87 12,933 244,079 114,271 Mar 26, 2013, 04:32 PM
Cantor Maria E SVP, Corporate Affairs Mar 22, 2013 Option Exercise $19.38 5,877 113,896 58,025 Mar 26, 2013, 04:32 PM
BERGER HARVEY J M D Chairman & CEO Mar 22, 2013 Option Exercise $19.38 46,148 894,348 1,745,543 Mar 26, 2013, 04:30 PM
BERGER HARVEY J M D Chairman & CEO Mar 20, 2013 Option Exercise $20.45 16,065 328,529 1,694,024 Mar 22, 2013, 07:07 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 20, 2013 Option Exercise $20.45 2,722 55,665 172,155 Mar 22, 2013, 07:02 PM
Duvall Martin J SVP, Commercial Operations Mar 22, 2013 Sale $19.53 576 11,249 2,854 Mar 22, 2013, 06:51 PM
Keane Raymond T SVP General Counsel & CCO Mar 22, 2013 Sale $19.46 2,334 45,423 38,347 Mar 22, 2013, 06:38 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 22, 2013 Sale $19.46 2,400 46,698 41,882 Mar 22, 2013, 06:31 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 22, 2013 Sale $19.46 2,400 46,694 60,807 Mar 22, 2013, 06:29 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 22, 2013 Sale $19.46 2,400 46,694 94,871 Mar 22, 2013, 06:09 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 22, 2013 Sale $19.46 1,600 31,135 189,498 Mar 22, 2013, 06:05 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 22, 2013 Sale $19.46 6,667 129,718 338,039 Mar 22, 2013, 06:03 PM
Cantor Maria E SVP, Corporate Affairs Mar 22, 2013 Sale $19.45 3,667 71,335 42,235 Mar 22, 2013, 05:14 PM
BERGER HARVEY J M D Chairman & CEO Mar 13, 2013 Sale $22.06 50,000 1,102,990 1,676,089 Mar 14, 2013, 04:33 PM
BERGER HARVEY J M D Chairman & CEO Mar 13, 2013 Sale $22.07 2,700 59,587 27,457 Mar 14, 2013, 04:33 PM
BERGER HARVEY J M D Chairman & CEO Mar 12, 2013 Sale $22.04 50,000 1,101,755 1,726,089 Mar 14, 2013, 04:33 PM
BERGER HARVEY J M D Chairman & CEO Mar 12, 2013 Sale $22.04 2,700 59,516 30,157 Mar 14, 2013, 04:33 PM
Cantor Maria E SVP, Corporate Affairs Mar 12, 2013 Sale $22.00 2,105 46,310 38,568 Mar 13, 2013, 04:35 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 04, 2013 Sale $21.00 9,838 206,598 331,372 Mar 05, 2013, 04:44 PM
CLACKSON TIMOTHY P President, R&D, CSO Jan 15, 2013 Option Exercise $5.05 57,939 292,414 341,210 Jan 17, 2013, 04:44 PM
FITZGERALD EDWARD M Executive VP, CFO Jan 02, 2013 Sale $20.08 25,000 501,890 166,543 Jan 03, 2013, 04:30 PM
LAVIDAS ATHANESE Director Dec 21, 2012 Sale $20.31 10,500 213,209 80,131 Dec 27, 2012, 04:45 PM
CLACKSON TIMOTHY P President, R&D, CSO Dec 20, 2012 Option Exercise $5.23 27,000 141,210 282,940 Dec 21, 2012, 04:28 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Dec 18, 2012 Option Exercise $20.18 3,758 75,836 91,271 Dec 20, 2012, 04:46 PM
Cantor Maria E SVP, Corporate Affairs Dec 18, 2012 Option Exercise $20.18 5,324 107,438 40,673 Dec 20, 2012, 04:44 PM
CLACKSON TIMOTHY P President, R&D, CSO Dec 18, 2012 Option Exercise $20.18 8,142 164,306 255,940 Dec 20, 2012, 04:41 PM
FITZGERALD EDWARD M Executive VP, CFO Dec 18, 2012 Option Exercise $20.18 8,142 164,306 191,357 Dec 20, 2012, 04:39 PM
Haluska Frank SVP, Clinical R&D, CMO Dec 18, 2012 Option Exercise $20.18 5,324 107,438 57,207 Dec 20, 2012, 04:37 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Dec 18, 2012 Option Exercise $20.18 3,758 75,836 38,282 Dec 20, 2012, 04:35 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Dec 18, 2012 Option Exercise $20.18 3,758 75,836 187,098 Dec 20, 2012, 04:30 PM
BERGER HARVEY J M D Chairman & CEO Dec 18, 2012 Option Exercise $20.18 26,094 526,577 2,226,089 Dec 20, 2012, 04:27 PM
Keane Raymond T SVP General Counsel & CCO Dec 18, 2012 Option Exercise $20.18 3,236 65,302 36,014 Dec 20, 2012, 04:24 PM
LAMARCHE JAY R Director Oct 01, 2012 Sale $24.99 10,000 249,932 400,705 Oct 03, 2012, 04:02 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Oct 01, 2012 Option Exercise $1.30 7,500 9,750 93,019 Oct 02, 2012, 04:13 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Oct 01, 2012 Sale $25.00 7,500 187,500 85,519 Oct 02, 2012, 04:13 PM
FITZGERALD EDWARD M Executive VP, CFO Oct 01, 2012 Sale $24.17 25,000 604,187 179,767 Oct 02, 2012, 04:11 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 19, 2012 Option Exercise $1.30 7,500 9,750 93,019 Sep 20, 2012, 12:34 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 19, 2012 Sale $24.00 7,500 180,000 85,519 Sep 20, 2012, 12:34 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 19, 2012 Option Exercise $5.23 11,375 59,491 201,231 Sep 20, 2012, 12:32 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 19, 2012 Sale $24.00 19,375 465,000 189,856 Sep 20, 2012, 12:32 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 11, 2012 Option Exercise $1.30 7,500 9,750 93,019 Sep 12, 2012, 04:10 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Sep 11, 2012 Sale $23.00 7,500 172,500 85,519 Sep 12, 2012, 04:10 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 11, 2012 Option Exercise $5.23 11,375 59,491 201,231 Sep 12, 2012, 04:05 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 11, 2012 Sale $23.00 19,375 445,625 189,856 Sep 12, 2012, 04:05 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 11, 2012 Option Exercise $5.23 11,375 59,491 201,231 Sep 12, 2012, 04:02 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 11, 2012 Sale $23.00 19,375 445,625 189,856 Sep 12, 2012, 04:02 PM
LAMARCHE JAY R Director Sep 06, 2012 Option Exercise $2.66 15,000 39,900 533,893 Sep 11, 2012, 04:15 PM
LAMARCHE JAY R Director Sep 06, 2012 Option Exercise $2.66 15,000 39,900 525,205 Sep 07, 2012, 04:55 PM
Keane Raymond T SVP General Counsel & CCO Sep 06, 2012 Option Exercise $2.39 10,000 23,900 41,500 Sep 07, 2012, 04:18 PM
Keane Raymond T SVP General Counsel & CCO Sep 06, 2012 Sale $22.00 10,000 220,000 31,500 Sep 07, 2012, 04:18 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 06, 2012 Option Exercise $5.23 11,375 59,491 205,700 Sep 07, 2012, 04:16 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 06, 2012 Sale $22.00 19,375 426,250 197,856 Sep 07, 2012, 04:16 PM
Keane Raymond T SVP General Counsel & CCO Sep 04, 2012 Sale $21.00 7,780 163,380 31,500 Sep 05, 2012, 04:18 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 04, 2012 Option Exercise $5.23 8,050 42,102 221,906 Sep 05, 2012, 04:15 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Sep 04, 2012 Sale $21.00 16,050 337,050 213,856 Sep 05, 2012, 04:15 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 30, 2012 Option Exercise $3.25 10,001 32,503 244,170 Sep 04, 2012, 04:08 PM
LAMARCHE JAY R Director Aug 15, 2012 Sale $20.00 20,000 400,032 518,893 Aug 16, 2012, 04:10 PM
Keane Raymond T SVP General Counsel & CCO Aug 15, 2012 Option Exercise $2.39 10,000 23,900 49,280 Aug 16, 2012, 04:09 PM
Keane Raymond T SVP General Counsel & CCO Aug 15, 2012 Sale $20.00 10,000 200,000 39,280 Aug 16, 2012, 04:09 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 15, 2012 Option Exercise $7.56 36,843 278,533 271,012 Aug 16, 2012, 04:07 PM
CLACKSON TIMOTHY P President, R&D, CSO Aug 15, 2012 Sale $20.00 36,843 736,860 234,169 Aug 16, 2012, 04:07 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Aug 15, 2012 Sale $20.00 8,000 160,000 213,856 Aug 16, 2012, 04:05 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Jul 30, 2012 Option Exercise $5.49 25,000 137,250 61,640 Aug 01, 2012, 04:45 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Jul 30, 2012 Sale $19.00 28,600 543,400 33,040 Aug 01, 2012, 04:45 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Jul 30, 2012 Sale $19.00 8,000 152,000 221,856 Aug 01, 2012, 04:12 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 30, 2012 Option Exercise $5.23 23,234 121,514 257,403 Aug 01, 2012, 04:07 PM
CLACKSON TIMOTHY P President, R&D, CSO Jul 30, 2012 Sale $19.00 23,234 441,446 234,169 Aug 01, 2012, 04:07 PM
Keane Raymond T SVP General Counsel & CCO Jul 30, 2012 Sale $19.00 10,000 190,000 39,280 Aug 01, 2012, 04:06 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jul 30, 2012 Option Exercise $1.30 7,500 9,750 93,091 Aug 01, 2012, 04:05 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jul 30, 2012 Sale $19.00 7,500 142,500 85,519 Aug 01, 2012, 04:05 PM
Cantor Maria E SVP, Corporate Affairs Jul 30, 2012 Option Exercise $7.82 6,478 50,658 39,326 Aug 01, 2012, 04:04 PM
Cantor Maria E SVP, Corporate Affairs Jul 30, 2012 Sale $19.00 6,478 123,082 32,848 Aug 01, 2012, 04:04 PM
Keane Raymond T SVP General Counsel & CCO Jul 26, 2012 Option Exercise $2.39 10,000 23,900 59,280 Jul 27, 2012, 03:03 PM
Keane Raymond T SVP General Counsel & CCO Jul 26, 2012 Sale $18.00 10,000 180,000 49,280 Jul 27, 2012, 03:03 PM
LAVIDAS ATHANESE Director Jul 20, 2012 Sale $18.00 5,000 89,977 90,631 Jul 23, 2012, 04:33 PM
FITZGERALD EDWARD M Executive VP, CFO Jul 02, 2012 Sale $17.64 25,000 440,950 204,767 Jul 05, 2012, 04:23 PM
Cantor Maria E SVP, Corporate Affairs Jun 25, 2012 Sale $17.11 1,765 30,199 32,337 Jun 26, 2012, 04:29 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jun 22, 2012 Option Exercise $1.30 7,500 9,750 92,595 Jun 25, 2012, 04:30 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Jun 22, 2012 Sale $17.50 7,500 131,269 85,095 Jun 25, 2012, 04:30 PM
LAVIDAS ATHANESE Director Jun 20, 2012 Sale $17.41 5,000 87,028 95,631 Jun 22, 2012, 04:30 PM
Cantor Maria E SVP, Corporate Affairs Jun 19, 2012 Option Exercise $3.08 7,500 23,100 41,602 Jun 21, 2012, 04:03 PM
Cantor Maria E SVP, Corporate Affairs Jun 19, 2012 Sale $18.00 7,500 135,000 34,102 Jun 21, 2012, 04:03 PM
BERGER HARVEY J M D Chairman & CEO Jun 13, 2012 Option Exercise $16.79 5,955 99,984 2,189,683 Jun 15, 2012, 04:27 PM
BERGER HARVEY J M D Chairman & CEO Jun 13, 2012 Option Exercise $4.05 24,691 99,999 2,195,638 Jun 15, 2012, 04:27 PM
LAVIDAS ATHANESE Director Jun 05, 2012 Option Exercise $6.39 25,000 159,750 125,631 Jun 07, 2012, 04:21 PM
LAVIDAS ATHANESE Director Jun 05, 2012 Sale $16.05 25,000 401,280 100,631 Jun 07, 2012, 04:21 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer May 21, 2012 Option Exercise $4.19 26,075 109,254 263,931 May 23, 2012, 04:05 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 26, 2012 Sale $16.00 8,000 128,000 229,856 May 23, 2012, 04:05 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer May 21, 2012 Sale $16.54 26,075 431,398 237,856 May 23, 2012, 04:05 PM
LAVIDAS ATHANESE Director May 21, 2012 Sale $16.54 5,000 82,690 100,631 May 23, 2012, 04:04 PM
DODION PIERRE F SVP, Corp. Dev. & Operations May 16, 2012 Sale $17.50 22,130 387,275 36,640 May 17, 2012, 04:30 PM
FITZGERALD EDWARD M Executive VP, CFO May 03, 2012 Option Exercise $4.63 60,000 277,800 229,548 May 04, 2012, 04:33 PM
CLACKSON TIMOTHY P President, R&D, CSO May 02, 2012 Option Exercise $7.44 20,000 148,800 253,778 May 04, 2012, 04:31 PM
CLACKSON TIMOTHY P President, R&D, CSO May 02, 2012 Sale $17.00 20,000 340,000 233,778 May 04, 2012, 04:31 PM
Haluska Frank SVP, Clinical R&D, CMO May 02, 2012 Option Exercise $2.39 3,000 7,170 52,781 May 04, 2012, 04:29 PM
Haluska Frank SVP, Clinical R&D, CMO May 02, 2012 Sale $17.00 3,000 51,000 49,781 May 04, 2012, 04:29 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer May 02, 2012 Option Exercise $4.19 11,375 47,661 257,231 May 04, 2012, 04:27 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer May 02, 2012 Sale $17.00 19,375 329,375 245,856 May 04, 2012, 04:27 PM
LAVIDAS ATHANESE Director Apr 20, 2012 Sale $15.06 10,000 150,558 105,631 Apr 24, 2012, 04:30 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 17, 2012 Option Exercise $4.63 40,000 185,200 209,548 Apr 18, 2012, 04:33 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 17, 2012 Sale $15.00 40,000 600,000 169,548 Apr 18, 2012, 04:33 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 17, 2012 Sale $15.00 7,111 106,665 233,778 Apr 17, 2012, 04:28 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 13, 2012 Sale $14.83 31,600 468,628 240,889 Apr 17, 2012, 04:28 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 12, 2012 Sale $15.39 17,062 262,576 58,770 Apr 16, 2012, 04:27 PM
LAVIDAS ATHANESE Director Apr 09, 2012 Sale $15.76 15,000 236,350 115,631 Apr 11, 2012, 04:31 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 02, 2012 Option Exercise $7.82 10,667 83,416 86,499 Apr 04, 2012, 04:02 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 02, 2012 Sale $16.11 10,667 171,887 75,832 Apr 04, 2012, 04:02 PM
Cantor Maria E SVP, Corporate Affairs Apr 03, 2012 Sale $16.18 3,400 55,027 33,327 Apr 03, 2012, 06:02 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 03, 2012 Sale $16.18 5,200 84,134 272,489 Apr 03, 2012, 05:58 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 26, 2012 Sale $16.34 26,061 425,876 264,689 Apr 03, 2012, 05:58 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Apr 03, 2012 Sale $16.19 2,400 38,844 245,856 Apr 03, 2012, 05:57 PM
Keane Raymond T SVP General Counsel & CCO Apr 03, 2012 Sale $16.19 2,067 33,455 48,980 Apr 03, 2012, 05:56 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 03, 2012 Sale $16.18 5,200 84,156 167,880 Apr 03, 2012, 05:56 PM
BERGER HARVEY J M D Chairman & CEO Apr 02, 2012 Option Exercise $16.23 17,396 282,337 2,170,947 Apr 03, 2012, 05:54 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Apr 02, 2012 Option Exercise $16.23 1,905 30,918 85,095 Apr 03, 2012, 05:54 PM
Haluska Frank SVP, Clinical R&D, CMO Apr 03, 2012 Sale $16.18 4,250 68,767 49,781 Apr 03, 2012, 05:53 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Apr 03, 2012 Sale $16.18 2,400 38,836 75,832 Apr 03, 2012, 05:52 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 26, 2012 Option Exercise $6.39 7,500 47,925 298,250 Mar 28, 2012, 04:18 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 26, 2012 Sale $16.00 7,500 120,000 290,750 Mar 28, 2012, 04:18 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 26, 2012 Option Exercise $4.19 11,375 47,661 253,631 Mar 28, 2012, 04:17 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 26, 2012 Sale $16.00 11,375 182,000 242,256 Mar 28, 2012, 04:17 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 26, 2012 Option Exercise $5.49 25,000 137,250 97,232 Mar 28, 2012, 04:16 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 26, 2012 Sale $16.50 25,000 412,500 72,232 Mar 28, 2012, 04:16 PM
Cantor Maria E SVP, Corporate Affairs Mar 26, 2012 Option Exercise $3.08 6,000 18,480 52,227 Mar 28, 2012, 04:15 PM
Cantor Maria E SVP, Corporate Affairs Mar 27, 2012 Sale $16.23 18,000 292,138 28,227 Mar 28, 2012, 04:15 PM
Cantor Maria E SVP, Corporate Affairs Mar 26, 2012 Sale $16.00 6,000 96,000 46,227 Mar 28, 2012, 04:15 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 26, 2012 Option Exercise $2.39 3,000 7,170 48,531 Mar 28, 2012, 04:15 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 26, 2012 Sale $16.00 3,000 48,000 45,531 Mar 28, 2012, 04:15 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 23, 2012 Sale $15.41 6,667 102,718 45,531 Mar 26, 2012, 04:45 PM
Keane Raymond T SVP General Counsel & CCO Mar 23, 2012 Sale $15.41 10,533 162,271 45,880 Mar 26, 2012, 04:44 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 23, 2012 Sale $15.29 24,901 380,712 89,000 Mar 26, 2012, 04:43 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 23, 2012 Sale $15.41 12,933 199,239 160,080 Mar 26, 2012, 04:41 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 22, 2012 Option Exercise $15.68 10,343 162,178 81,000 Mar 26, 2012, 04:39 PM
BERGER HARVEY J M D Chairman & CEO Mar 22, 2012 Option Exercise $15.68 40,776 639,368 2,146,676 Mar 26, 2012, 04:38 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 23, 2012 Sale $15.41 15,333 236,211 290,750 Mar 26, 2012, 04:37 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 23, 2012 Sale $15.41 10,533 162,274 242,256 Mar 26, 2012, 04:36 PM
BERGER HARVEY J M D Chairman & CEO Mar 20, 2012 Option Exercise $15.05 10,438 157,092 2,089,786 Mar 22, 2012, 04:34 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 20, 2012 Sale $15.02 18,800 282,314 226,456 Mar 21, 2012, 06:08 PM
Keane Raymond T SVP General Counsel & CCO Mar 20, 2012 Sale $15.02 8,400 126,155 30,380 Mar 21, 2012, 06:06 PM
Haluska Frank SVP, Clinical R&D, CMO Mar 20, 2012 Sale $15.02 15,000 225,240 38,865 Mar 21, 2012, 06:05 PM
FITZGERALD EDWARD M Executive VP, CFO Mar 20, 2012 Sale $15.02 31,200 468,605 140,680 Mar 21, 2012, 06:04 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Mar 20, 2012 Sale $15.01 12,980 194,799 76,800 Mar 21, 2012, 06:03 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 20, 2012 Sale $15.02 36,400 546,622 267,750 Mar 21, 2012, 06:02 PM
Cantor Maria E SVP, Corporate Affairs Mar 20, 2012 Sale $15.02 14,000 210,218 28,277 Mar 21, 2012, 06:02 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 16, 2012 Option Exercise $4.13 15,064 62,192 213,150 Mar 19, 2012, 04:30 PM
BERGER HARVEY J M D Chairman & CEO Mar 10, 2012 Option Exercise $14.95 66,800 998,660 2,008,424 Mar 13, 2012, 05:05 PM
LAMARCHE JAY R Director Feb 28, 2012 Option Exercise $4.44 20,000 88,800 538,893 Mar 01, 2012, 04:29 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Feb 28, 2012 Option Exercise $3.93 11,375 44,703 209,631 Mar 01, 2012, 04:28 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Feb 28, 2012 Sale $15.50 11,375 176,313 198,256 Mar 01, 2012, 04:28 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Feb 23, 2012 Option Exercise $5.49 25,000 137,250 55,780 Feb 24, 2012, 04:31 PM
DODION PIERRE F SVP, Corp. Dev. & Operations Feb 23, 2012 Sale $15.00 25,000 375,000 30,780 Feb 24, 2012, 04:31 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Feb 23, 2012 Sale $15.00 4,100 61,500 198,256 Feb 24, 2012, 04:30 PM
Haluska Frank SVP, Clinical R&D, CMO Feb 21, 2012 Option Exercise $2.39 4,500 10,755 28,365 Feb 23, 2012, 04:32 PM
Haluska Frank SVP, Clinical R&D, CMO Feb 21, 2012 Sale $14.51 4,500 65,277 23,865 Feb 23, 2012, 04:32 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Feb 21, 2012 Option Exercise $3.90 22,800 88,920 237,456 Feb 23, 2012, 04:31 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Feb 21, 2012 Sale $14.50 35,100 509,032 214,656 Feb 23, 2012, 04:31 PM
BERGER HARVEY J M D Chairman & CEO Feb 15, 2012 Option Exercise $15.05 22,912 344,826 1,915,224 Feb 17, 2012, 04:30 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 14, 2012 Option Exercise $3.90 16,500 64,350 138,150 Feb 17, 2012, 04:29 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 14, 2012 Sale $15.50 16,500 255,750 121,650 Feb 17, 2012, 04:29 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 14, 2012 Option Exercise $4.09 76,436 312,908 196,318 Feb 16, 2012, 04:29 PM
CLACKSON TIMOTHY P President, R&D, CSO Feb 14, 2012 Sale $15.12 76,436 1,155,781 119,882 Feb 16, 2012, 04:29 PM
Keane Raymond T SVP General Counsel & CCO Feb 14, 2012 Option Exercise $1.30 12,500 16,250 30,280 Feb 16, 2012, 04:28 PM
Keane Raymond T SVP General Counsel & CCO Feb 14, 2012 Sale $15.13 12,500 189,178 17,780 Feb 16, 2012, 04:28 PM
LAMARCHE JAY R Director Jan 27, 2012 Sale $15.05 26,900 404,974 500,534 Jan 31, 2012, 04:32 PM
LAMARCHE JAY R Director Jan 26, 2012 Sale $15.04 3,100 46,627 527,434 Jan 27, 2012, 04:24 PM
BERGER HARVEY J M D Chairman & CEO Jul 26, 2011 Option Exercise $4.80 20,837 100,018 1,938,136 Jul 26, 2011, 04:30 PM
CLACKSON TIMOTHY P President, R&D, CSO Jun 07, 2011 Option Exercise $8.65 43,766 378,576 196,318 Jun 09, 2011, 04:22 PM
CLACKSON TIMOTHY P President, R&D, CSO Jun 07, 2011 Option Exercise $5.65 60,000 339,000 240,084 Jun 09, 2011, 04:22 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Jun 07, 2011 Option Exercise $8.65 44,145 381,854 214,656 Jun 09, 2011, 04:21 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Jun 07, 2011 Option Exercise $5.65 60,000 339,000 258,801 Jun 09, 2011, 04:21 PM
LAMARCHE JAY R Director May 09, 2011 Option Exercise $9.19 15,369 141,241 530,534 May 11, 2011, 04:32 PM
LAMARCHE JAY R Director May 09, 2011 Option Exercise $5.65 25,000 141,250 545,903 May 11, 2011, 04:32 PM
DODION PIERRE F Senior VP, Corp. Development Apr 11, 2011 Option Exercise $7.76 7,938 61,599 30,780 Apr 13, 2011, 06:33 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Apr 11, 2011 Option Exercise $7.76 15,875 123,190 59,010 Apr 13, 2011, 06:31 PM
CLACKSON TIMOTHY P President, R&D, CSO Apr 11, 2011 Option Exercise $7.76 13,289 103,123 180,084 Apr 13, 2011, 06:30 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Apr 11, 2011 Option Exercise $7.76 6,985 54,204 198,801 Apr 13, 2011, 06:29 PM
FITZGERALD EDWARD M Executive VP, CFO Apr 11, 2011 Option Exercise $7.76 10,067 78,120 93,880 Apr 13, 2011, 06:27 PM
LAMARCHE JAY R Director Mar 25, 2011 Sale $7.01 25,000 175,277 520,903 Mar 29, 2011, 04:29 PM
Keane Raymond T SVP General Counsel & CCO Mar 22, 2011 Option Exercise $6.39 8,554 54,660 17,780 Mar 24, 2011, 05:41 PM
Haluska Frank VP, Clinical R&D, CMO Mar 22, 2011 Option Exercise $6.39 4,400 28,116 23,865 Mar 24, 2011, 05:38 PM
DODION PIERRE F Senior VP, Corp. Development Mar 22, 2011 Option Exercise $6.39 6,616 42,276 13,718 Mar 24, 2011, 05:35 PM
CLACKSON TIMOTHY P President, R&D, CSO Mar 22, 2011 Option Exercise $6.39 12,273 78,424 141,373 Mar 24, 2011, 05:31 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Mar 22, 2011 Option Exercise $6.39 10,449 66,769 24,885 Mar 24, 2011, 05:30 PM
BERSTEIN DAVID L Senior VP, Chief IP Officer Mar 22, 2011 Option Exercise $6.39 8,509 54,373 181,910 Mar 24, 2011, 05:29 PM
LAMARCHE JAY R Director Feb 02, 2011 Sale $6.48 25,000 161,925 545,903 Feb 04, 2011, 04:16 PM
LAMARCHE JAY R Director Jan 11, 2011 Sale $5.51 25,000 137,675 560,003 Jan 14, 2011, 04:23 PM
LAMARCHE JAY R Director Jan 11, 2011 Sale $5.50 25,000 137,388 560,003 Jan 13, 2011, 04:30 PM
LAMARCHE JAY R Director Dec 20, 2010 Sale $5.00 25,000 125,006 576,903 Dec 22, 2010, 04:30 PM
Bollag Daniel M Sr. VP, Reg. Affairs & Quality Oct 26, 2010 Buy $3.70 3,000 11,100 3,000 Oct 27, 2010, 04:30 PM
CLACKSON TIMOTHY P Pres., R & D., Chief Sci. Off. Oct 26, 2010 Buy $3.70 10,000 37,000 117,437 Oct 27, 2010, 04:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Cole Hugh M SVP, Chief Business Officer 06/25/2015 54,304
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 01/31/2017 349,293
CLACKSON TIMOTHY P President, R&D, CSO 01/31/2017 228,886
Panayiotopoulos Paris President and CEO 01/17/2017 788,934
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 01/09/2017 250,240
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 01/09/2017 760,960
CLACKSON TIMOTHY P President, R&D, CSO 10/24/2016 187,739
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 10/03/2016 637,812
CLACKSON TIMOTHY P President, R&D, CSO 09/28/2016 122,311
CLACKSON TIMOTHY P President, R&D, CSO 09/22/2016 268,536
CLACKSON TIMOTHY P President, R&D, CSO 09/15/2016 464,266
CLACKSON TIMOTHY P President, R&D, CSO 09/15/2016 696,398
CLACKSON TIMOTHY P President, R&D, CSO 08/22/2016 203,538
CLACKSON TIMOTHY P President, R&D, CSO 08/12/2016 192,250
CLACKSON TIMOTHY P President, R&D, CSO 08/12/2016 262,500
CLACKSON TIMOTHY P President, R&D, CSO 07/22/2016 148,230
Panayiotopoulos Paris President and CEO 07/13/2016 204,283
CLACKSON TIMOTHY P President, R&D, CSO 07/01/2016 238,585
CLACKSON TIMOTHY P President, R&D, CSO 07/01/2016 459,634
Cole Hugh M SVP, Chief Business Officer 06/28/2016 42,385
CLACKSON TIMOTHY P President, R&D, CSO 06/22/2016 174,638
LAVIDAS ATHANESE Director 06/13/2016 54,900
LAVIDAS ATHANESE Director 06/15/2016 302,787
LAVIDAS ATHANESE Director 06/14/2016 128,800
LAVIDAS ATHANESE Director 06/13/2016 82,050
LAVIDAS ATHANESE Director 06/15/2016 381,137
LAVIDAS ATHANESE Director 06/14/2016 162,852
Radaelli Massimo Director 06/13/2016 523,551
Radaelli Massimo Director 06/10/2016 30,494
Radaelli Massimo Director 06/14/2016 30,687
Radaelli Massimo Director 06/10/2016 187,480
Radaelli Massimo Director 06/14/2016 50,834
Radaelli Massimo Director 06/13/2016 657,821
CLACKSON TIMOTHY P President, R&D, CSO 05/23/2016 143,430
Panayiotopoulos Paris President and CEO 05/12/2016 199,996
Haluska Frank SVP, Clinical R&D, CMO 04/29/2016 40,452
Cantor Maria E SVP, Corporate Affairs 04/29/2016 31,118
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 04/29/2016 40,452
Cole Hugh M SVP, Chief Business Officer 04/29/2016 40,452
CLACKSON TIMOTHY P President, R&D, CSO 05/02/2016 83,478
Duvall Martin J EVP, CCO 04/29/2016 42,003
CLACKSON TIMOTHY P President, R&D, CSO 04/22/2016 157,864
DesRosier Thomas EVP, General Counsel 02/18/2016 92,401
CLACKSON TIMOTHY P President, R&D, CSO 03/22/2016 156,871
Duvall Martin J EVP, CCO 03/19/2016 25,867
BERSTEIN DAVID L SVP, Chief IP Counsel 03/21/2016 15,356
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/21/2016 25,871
Cantor Maria E SVP, Corporate Affairs 03/19/2016 23,102
CLACKSON TIMOTHY P President, R&D, CSO 03/19/2016 35,039
FITZGERALD EDWARD M Executive VP 03/21/2016 35,037
Haluska Frank SVP, Clinical R&D, CMO 03/21/2016 23,116
Cole Hugh M SVP, Chief Business Officer 03/16/2016 15,140
Cole Hugh M SVP, Chief Business Officer 03/16/2016 46,575
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/15/2016 141,009
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/15/2016 4,875
FITZGERALD EDWARD M Executive VP, CFO 03/03/2016 58,866
BERSTEIN DAVID L SVP, Chief IP Counsel 03/03/2016 58,887
Duvall Martin J EVP, CCO 03/03/2016 58,863
Cantor Maria E SVP, Corporate Affairs 03/03/2016 58,869
CLACKSON TIMOTHY P President, R&D, CSO 03/03/2016 58,867
CLACKSON TIMOTHY P President, R&D, CSO 03/02/2016 150,282
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/03/2016 58,852
Haluska Frank SVP, Clinical R&D, CMO 03/03/2016 64,733
Panayiotopoulos Paris President and CEO 02/01/2016 299,996
Duvall Martin J EVP, CCO 02/01/2016 70,578
CLACKSON TIMOTHY P President, R&D, CSO 02/01/2016 70,517
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 02/01/2016 70,548
Haluska Frank SVP, Clinical R&D, CMO 02/01/2016 77,587
BERSTEIN DAVID L SVP, Chief IP Counsel 02/01/2016 70,515
FITZGERALD EDWARD M Executive VP, CFO 02/01/2016 70,515
Cantor Maria E SVP, Corporate Affairs 02/01/2016 77,745
BERGER HARVEY J M D Chairman & CEO 12/31/2015 1,777,381
BERSTEIN DAVID L SVP, Chief IP Counsel 09/28/2015 32,315
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/28/2015 32,315
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/28/2015 32,315
Duvall Martin J EVP, CCO 09/28/2015 32,317
Cantor Maria E SVP, Corporate Affairs 09/28/2015 32,327
FITZGERALD EDWARD M Executive VP, CFO 09/28/2015 56,551
Haluska Frank SVP, Clinical R&D, CMO 09/28/2015 35,502
CLACKSON TIMOTHY P President, R&D, CSO 09/28/2015 56,560
BERSTEIN DAVID L SVP, Chief IP Counsel 09/28/2015 32,315
Cantor Maria E SVP, Corporate Affairs 09/01/2015 24,557
FITZGERALD EDWARD M Executive VP, CFO 08/28/2015 328,580
Cantor Maria E SVP, Corporate Affairs 08/28/2015 12,680
CLACKSON TIMOTHY P President, R&D, CSO 07/16/2015 59,797
Duvall Martin J EVP, CCO 07/16/2015 11,956
FITZGERALD EDWARD M Executive VP, CFO 07/16/2015 59,793
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 07/16/2015 34,164
Cantor Maria E SVP, Corporate Affairs 07/16/2015 34,162
BERSTEIN DAVID L SVP, Chief IP Counsel 07/16/2015 34,162
Haluska Frank SVP, Clinical R&D, CMO 07/16/2015 37,575
BERGER HARVEY J M D Chairman & CEO 07/15/2015 145,040
FITZGERALD EDWARD M Executive VP, CFO 05/01/2015 453,600
FITZGERALD EDWARD M Executive VP, CFO 05/01/2015 528,000
CLACKSON TIMOTHY P President, R&D, CSO 04/23/2015 1,175,777
BERGER HARVEY J M D Chairman & CEO 03/26/2015 1,039,175
BERGER HARVEY J M D Chairman & CEO 03/26/2015 1,134,000
BERSTEIN DAVID L SVP, Chief IP Counsel 03/20/2015 21,026
BERSTEIN DAVID L SVP, Chief IP Counsel 03/23/2015 17,118
Cantor Maria E SVP, Corporate Affairs and HR 03/19/2015 24,255
Cantor Maria E SVP, Corporate Affairs and HR 03/23/2015 34,491
Cantor Maria E SVP, Corporate Affairs and HR 03/20/2015 31,627
Cantor Maria E SVP, Corporate Affairs and HR 03/19/2015 84,114
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/20/2015 35,390
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/23/2015 25,661
FITZGERALD EDWARD M Executive VP, CFO 03/23/2015 35,630
FITZGERALD EDWARD M Executive VP, CFO 03/20/2015 47,908
Duvall Martin J EVP, CCO 03/23/2015 7,145
Duvall Martin J EVP, CCO 03/20/2015 35,381
Haluska Frank SVP, Clinical R&D, CMO 03/20/2015 31,634
Haluska Frank SVP, Clinical R&D, CMO 03/23/2015 28,229
CLACKSON TIMOTHY P President, R&D, CSO 03/19/2015 156,167
CLACKSON TIMOTHY P President, R&D, CSO 03/23/2015 57,016
CLACKSON TIMOTHY P President, R&D, CSO 03/20/2015 47,910
CLACKSON TIMOTHY P President, R&D, CSO 03/19/2015 185,913
BERSTEIN DAVID L SVP, Chief IP Counsel 03/20/2015 21,026
BERSTEIN DAVID L SVP, Chief IP Counsel 03/23/2015 17,118
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/16/2015 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/16/2015 296,651
CLACKSON TIMOTHY P President, R&D, CSO 02/20/2015 173,419
CLACKSON TIMOTHY P President, R&D, CSO 02/20/2015 392,280
BERGER HARVEY J M D Chairman & CEO 02/11/2015 84,569
BERGER HARVEY J M D Chairman & CEO 02/12/2015 86,280
Haluska Frank SVP, Clinical R&D, CMO 02/02/2015 102,107
Cantor Maria E SVP, Corporate Affairs and HR 02/02/2015 102,089
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 02/02/2015 92,823
CLACKSON TIMOTHY P President, R&D, CSO 02/02/2015 92,820
Duvall Martin J EVP, CCO 02/02/2015 92,823
FITZGERALD EDWARD M Executive VP, CFO 02/02/2015 92,849
BERSTEIN DAVID L SVP, Chief IP Counsel 02/02/2015 92,826
BERGER HARVEY J M D Chairman & CEO 01/23/2015 77,250
BERGER HARVEY J M D Chairman & CEO 01/22/2015 76,990
Schlesinger Sarah J. Director 01/14/2015 8,125
Schlesinger Sarah J. Director 01/13/2015 9,061
BERGER HARVEY J M D Chairman & CEO 12/18/2014 81,770
BERGER HARVEY J M D Chairman & CEO 12/17/2014 76,875
Schlesinger Sarah J. Director 12/17/2014 7,943
Schlesinger Sarah J. Director 12/16/2014 7,891
Cantor Maria E SVP, Corporate Affairs and HR 11/24/2014 12,243
BERGER HARVEY J M D Chairman & CEO 11/20/2014 76,889
BERGER HARVEY J M D Chairman & CEO 11/19/2014 76,853
Schlesinger Sarah J. Director 11/12/2014 8,086
Schlesinger Sarah J. Director 11/11/2014 8,190
BERGER HARVEY J M D Chairman & CEO 10/16/2014 67,317
BERGER HARVEY J M D Chairman & CEO 10/15/2014 63,727
Schlesinger Sarah J. Director 10/15/2014 6,539
Schlesinger Sarah J. Director 10/14/2014 6,591
BERGER HARVEY J M D Chairman & CEO 09/03/2014 78,859
BERGER HARVEY J M D Chairman & CEO 09/02/2014 77,777
BERSTEIN DAVID L SVP, GC and Chief IP Officer 09/09/2014 40,929
BERSTEIN DAVID L SVP, GC and Chief IP Officer 09/09/2014 40,925
BERGER HARVEY J M D Chairman & CEO 09/09/2014 716,525
BERGER HARVEY J M D Chairman & CEO 09/09/2014 784,500
BERGER HARVEY J M D Chairman & CEO 09/03/2014 78,859
BERGER HARVEY J M D Chairman & CEO 09/02/2014 77,777
Schlesinger Sarah J. Director 08/12/2014 7,176
Schlesinger Sarah J. Director 09/10/2014 7,475
Schlesinger Sarah J. Director 09/09/2014 7,709
Schlesinger Sarah J. Director 08/13/2014 7,423
FITZGERALD EDWARD M Executive VP, CFO 09/02/2014 261,500
FITZGERALD EDWARD M Executive VP, CFO 09/02/2014 310,835
Cantor Maria E SVP, Corporate Affairs and HR 09/02/2014 16,753
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/02/2014 34,125
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/02/2014 352,227
DENNER ALEXANDER J Director 08/15/2014 3,588,167
DENNER ALEXANDER J Director 08/15/2014 1,367,333
BERSTEIN DAVID L SVP, GC and Chief IP Officer 07/15/2014 14,527
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 07/15/2014 14,527
Cantor Maria E SVP, Corporate Affairs and HR 07/15/2014 14,527
CLACKSON TIMOTHY P President, R&D, CSO 07/15/2014 25,421
Haluska Frank SVP, Clinical R&D, CMO 07/15/2014 14,527
FITZGERALD EDWARD M Executive VP, CFO 07/15/2014 25,421
BERGER HARVEY J M D Chairman & CEO 07/15/2014 86,647
Duvall Martin J EVP, CCO 07/15/2014 5,085
Cantor Maria E SVP, Corporate Affairs and HR 06/02/2014 25,611
Haluska Frank SVP, Clinical R&D, CMO 04/02/2014 27,916
BERSTEIN DAVID L SVP, GC and Chief IP Officer 04/02/2014 19,718
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 04/02/2014 19,720
FITZGERALD EDWARD M Executive VP, CFO 04/01/2014 36,108
BERGER HARVEY J M D Chairman & CEO 04/01/2014 115,736
Cantor Maria E SVP, Corporate Affairs and HR 04/02/2014 34,907
CLACKSON TIMOTHY P President, R&D, CSO 04/02/2014 53,337
Cantor Maria E SVP, Corporate Affairs and HR 03/19/2014 16,880
Cantor Maria E SVP, Corporate Affairs and HR 03/21/2014 28,930
BERSTEIN DAVID L SVP, GC and Chief IP Officer 03/19/2014 12,334
BERSTEIN DAVID L SVP, GC and Chief IP Officer 03/21/2014 12,630
Haluska Frank SVP, Clinical R&D, CMO 03/19/2014 16,880
Haluska Frank SVP, Clinical R&D, CMO 03/21/2014 18,941
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/19/2014 20,770
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/21/2014 18,936
CLACKSON TIMOTHY P President, R&D, CSO 03/19/2014 28,190
CLACKSON TIMOTHY P President, R&D, CSO 03/21/2014 52,583
Duvall Martin J EVP, CCO 03/20/2014 4,301
Duvall Martin J EVP, CCO 03/19/2014 21,441
FITZGERALD EDWARD M Executive VP, CFO 03/20/2014 22,089
FITZGERALD EDWARD M Executive VP, CFO 03/19/2014 28,133
BERGER HARVEY J M D Chairman & CEO 03/20/2014 90,113
BERGER HARVEY J M D Chairman & CEO 03/19/2014 95,913
CLACKSON TIMOTHY P President, R&D, CSO 12/19/2013 50,115
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 12/19/2013 18,528
Cantor Maria E SVP, Corporate Affairs 12/19/2013 32,767
BERGER HARVEY J M D Chairman & CEO 12/18/2013 146,910
Haluska Frank SVP, Clinical R&D, CMO 12/19/2013 26,214
BERSTEIN DAVID L Senior VP, Chief IP Officer 12/19/2013 23,130
Duvall Martin J SVP, Commercial Operations 09/19/2013 234,628
CLACKSON TIMOTHY P President, R&D, CSO 09/06/2013 185,878
FITZGERALD EDWARD M Executive VP, CFO 08/15/2013 350,284
FITZGERALD EDWARD M Executive VP, CFO 08/15/2013 128,700
BERGER HARVEY J M D Chairman & CEO 08/14/2013 57,999
BERGER HARVEY J M D Chairman & CEO 08/14/2013 1,164,335
BERGER HARVEY J M D Chairman & CEO 08/13/2013 49,570
BERGER HARVEY J M D Chairman & CEO 08/13/2013 905,555
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 07/18/2013 126,639
BERSTEIN DAVID L Senior VP, Chief IP Officer 07/18/2013 158,290
Haluska Frank SVP, Clinical R&D, CMO 07/18/2013 126,642
DODION PIERRE F SVP, Corp. Dev. & Operations 07/18/2013 126,655
Keane Raymond T SVP General Counsel & CCO 07/18/2013 158,286
CLACKSON TIMOTHY P President, R&D, CSO 07/18/2013 277,045
Cantor Maria E SVP, Corporate Affairs 07/18/2013 158,299
BERGER HARVEY J M D Chairman & CEO 07/16/2013 56,623
BERGER HARVEY J M D Chairman & CEO 07/16/2013 2,866,478
BERGER HARVEY J M D Chairman & CEO 07/17/2013 52,912
BERGER HARVEY J M D Chairman & CEO 07/17/2013 980,705
BERGER HARVEY J M D Chairman & CEO 07/15/2013 729,600
FITZGERALD EDWARD M Executive VP, CFO 07/15/2013 277,565
BERGER HARVEY J M D Chairman & CEO 06/19/2013 97,208
BERGER HARVEY J M D Chairman & CEO 06/19/2013 104,415
BERGER HARVEY J M D Chairman & CEO 05/15/2013 48,983
BERGER HARVEY J M D Chairman & CEO 05/15/2013 675,970
BERGER HARVEY J M D Chairman & CEO 05/14/2013 48,600
BERGER HARVEY J M D Chairman & CEO 05/14/2013 900,295
BERGER HARVEY J M D Chairman & CEO 04/17/2013 1,800,590
BERGER HARVEY J M D Chairman & CEO 04/17/2013 97,201
Keane Raymond T SVP General Counsel & CCO 04/02/2013 46,625
Haluska Frank SVP, Clinical R&D, CMO 04/02/2013 61,339
Cantor Maria E SVP, Corporate Affairs 04/02/2013 76,665
CLACKSON TIMOTHY P President, R&D, CSO 04/02/2013 117,245
DODION PIERRE F SVP, Corp. Dev. & Operations 04/02/2013 43,295
BERGER HARVEY J M D Chairman & CEO 04/01/2013 360,290
BERSTEIN DAVID L Senior VP, Chief IP Officer 04/02/2013 43,322
FITZGERALD EDWARD M Executive VP, CFO 03/26/2013 242,492
Keane Raymond T SVP General Counsel & CCO 03/25/2013 248,482
DODION PIERRE F SVP, Corp. Dev. & Operations 03/25/2013 153,482
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/25/2013 198,807
Haluska Frank SVP, Clinical R&D, CMO 03/25/2013 100,672
CLACKSON TIMOTHY P President, R&D, CSO 03/25/2013 361,766
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/25/2013 244,079
Cantor Maria E SVP, Corporate Affairs 03/22/2013 113,896
BERGER HARVEY J M D Chairman & CEO 03/22/2013 894,348
BERGER HARVEY J M D Chairman & CEO 03/20/2013 328,529
FITZGERALD EDWARD M Executive VP, CFO 03/20/2013 55,665
Duvall Martin J SVP, Commercial Operations 03/22/2013 11,249
Keane Raymond T SVP General Counsel & CCO 03/22/2013 45,423
DODION PIERRE F SVP, Corp. Dev. & Operations 03/22/2013 46,698
Haluska Frank SVP, Clinical R&D, CMO 03/22/2013 46,694
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/22/2013 46,694
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/22/2013 31,135
CLACKSON TIMOTHY P President, R&D, CSO 03/22/2013 129,718
Cantor Maria E SVP, Corporate Affairs 03/22/2013 71,335
BERGER HARVEY J M D Chairman & CEO 03/13/2013 1,102,990
BERGER HARVEY J M D Chairman & CEO 03/13/2013 59,587
BERGER HARVEY J M D Chairman & CEO 03/12/2013 1,101,755
BERGER HARVEY J M D Chairman & CEO 03/12/2013 59,516
Cantor Maria E SVP, Corporate Affairs 03/12/2013 46,310
CLACKSON TIMOTHY P President, R&D, CSO 03/04/2013 206,598
CLACKSON TIMOTHY P President, R&D, CSO 01/15/2013 292,414
FITZGERALD EDWARD M Executive VP, CFO 01/02/2013 501,890
LAVIDAS ATHANESE Director 12/21/2012 213,209
CLACKSON TIMOTHY P President, R&D, CSO 12/20/2012 141,210
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 12/18/2012 75,836
Cantor Maria E SVP, Corporate Affairs 12/18/2012 107,438
CLACKSON TIMOTHY P President, R&D, CSO 12/18/2012 164,306
FITZGERALD EDWARD M Executive VP, CFO 12/18/2012 164,306
Haluska Frank SVP, Clinical R&D, CMO 12/18/2012 107,438
DODION PIERRE F SVP, Corp. Dev. & Operations 12/18/2012 75,836
BERSTEIN DAVID L Senior VP, Chief IP Officer 12/18/2012 75,836
BERGER HARVEY J M D Chairman & CEO 12/18/2012 526,577
Keane Raymond T SVP General Counsel & CCO 12/18/2012 65,302
LAMARCHE JAY R Director 10/01/2012 249,932
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 10/01/2012 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 10/01/2012 187,500
FITZGERALD EDWARD M Executive VP, CFO 10/01/2012 604,187
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/19/2012 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/19/2012 180,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/19/2012 59,491
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/19/2012 465,000
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/11/2012 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 09/11/2012 172,500
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/11/2012 59,491
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/11/2012 445,625
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/11/2012 59,491
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/11/2012 445,625
LAMARCHE JAY R Director 09/06/2012 39,900
LAMARCHE JAY R Director 09/06/2012 39,900
Keane Raymond T SVP General Counsel & CCO 09/06/2012 23,900
Keane Raymond T SVP General Counsel & CCO 09/06/2012 220,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/06/2012 59,491
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/06/2012 426,250
Keane Raymond T SVP General Counsel & CCO 09/04/2012 163,380
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/04/2012 42,102
BERSTEIN DAVID L Senior VP, Chief IP Officer 09/04/2012 337,050
CLACKSON TIMOTHY P President, R&D, CSO 08/30/2012 32,503
LAMARCHE JAY R Director 08/15/2012 400,032
Keane Raymond T SVP General Counsel & CCO 08/15/2012 23,900
Keane Raymond T SVP General Counsel & CCO 08/15/2012 200,000
CLACKSON TIMOTHY P President, R&D, CSO 08/15/2012 278,533
CLACKSON TIMOTHY P President, R&D, CSO 08/15/2012 736,860
BERSTEIN DAVID L Senior VP, Chief IP Officer 08/15/2012 160,000
DODION PIERRE F SVP, Corp. Dev. & Operations 07/30/2012 137,250
DODION PIERRE F SVP, Corp. Dev. & Operations 07/30/2012 543,400
BERSTEIN DAVID L Senior VP, Chief IP Officer 07/30/2012 152,000
CLACKSON TIMOTHY P President, R&D, CSO 07/30/2012 121,514
CLACKSON TIMOTHY P President, R&D, CSO 07/30/2012 441,446
Keane Raymond T SVP General Counsel & CCO 07/30/2012 190,000
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 07/30/2012 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 07/30/2012 142,500
Cantor Maria E SVP, Corporate Affairs 07/30/2012 50,658
Cantor Maria E SVP, Corporate Affairs 07/30/2012 123,082
Keane Raymond T SVP General Counsel & CCO 07/26/2012 23,900
Keane Raymond T SVP General Counsel & CCO 07/26/2012 180,000
LAVIDAS ATHANESE Director 07/20/2012 89,977
FITZGERALD EDWARD M Executive VP, CFO 07/02/2012 440,950
Cantor Maria E SVP, Corporate Affairs 06/25/2012 30,199
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 06/22/2012 9,750
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 06/22/2012 131,269
LAVIDAS ATHANESE Director 06/20/2012 87,028
Cantor Maria E SVP, Corporate Affairs 06/19/2012 23,100
Cantor Maria E SVP, Corporate Affairs 06/19/2012 135,000
BERGER HARVEY J M D Chairman & CEO 06/13/2012 99,984
BERGER HARVEY J M D Chairman & CEO 06/13/2012 99,999
LAVIDAS ATHANESE Director 06/05/2012 159,750
LAVIDAS ATHANESE Director 06/05/2012 401,280
BERSTEIN DAVID L Senior VP, Chief IP Officer 05/21/2012 109,254
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/26/2012 128,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 05/21/2012 431,398
LAVIDAS ATHANESE Director 05/21/2012 82,690
DODION PIERRE F SVP, Corp. Dev. & Operations 05/16/2012 387,275
FITZGERALD EDWARD M Executive VP, CFO 05/03/2012 277,800
CLACKSON TIMOTHY P President, R&D, CSO 05/02/2012 148,800
CLACKSON TIMOTHY P President, R&D, CSO 05/02/2012 340,000
Haluska Frank SVP, Clinical R&D, CMO 05/02/2012 7,170
Haluska Frank SVP, Clinical R&D, CMO 05/02/2012 51,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 05/02/2012 47,661
BERSTEIN DAVID L Senior VP, Chief IP Officer 05/02/2012 329,375
LAVIDAS ATHANESE Director 04/20/2012 150,558
FITZGERALD EDWARD M Executive VP, CFO 04/17/2012 185,200
FITZGERALD EDWARD M Executive VP, CFO 04/17/2012 600,000
CLACKSON TIMOTHY P President, R&D, CSO 04/17/2012 106,665
CLACKSON TIMOTHY P President, R&D, CSO 04/13/2012 468,628
DODION PIERRE F SVP, Corp. Dev. & Operations 04/12/2012 262,576
LAVIDAS ATHANESE Director 04/09/2012 236,350
DODION PIERRE F SVP, Corp. Dev. & Operations 04/02/2012 83,416
DODION PIERRE F SVP, Corp. Dev. & Operations 04/02/2012 171,887
Cantor Maria E SVP, Corporate Affairs 04/03/2012 55,027
CLACKSON TIMOTHY P President, R&D, CSO 04/03/2012 84,134
CLACKSON TIMOTHY P President, R&D, CSO 03/26/2012 425,876
BERSTEIN DAVID L Senior VP, Chief IP Officer 04/03/2012 38,844
Keane Raymond T SVP General Counsel & CCO 04/03/2012 33,455
FITZGERALD EDWARD M Executive VP, CFO 04/03/2012 84,156
BERGER HARVEY J M D Chairman & CEO 04/02/2012 282,337
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 04/02/2012 30,918
Haluska Frank SVP, Clinical R&D, CMO 04/03/2012 68,767
DODION PIERRE F SVP, Corp. Dev. & Operations 04/03/2012 38,836
CLACKSON TIMOTHY P President, R&D, CSO 03/26/2012 47,925
CLACKSON TIMOTHY P President, R&D, CSO 03/26/2012 120,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/26/2012 47,661
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/26/2012 182,000
DODION PIERRE F SVP, Corp. Dev. & Operations 03/26/2012 137,250
DODION PIERRE F SVP, Corp. Dev. & Operations 03/26/2012 412,500
Cantor Maria E SVP, Corporate Affairs 03/26/2012 18,480
Cantor Maria E SVP, Corporate Affairs 03/27/2012 292,138
Cantor Maria E SVP, Corporate Affairs 03/26/2012 96,000
Haluska Frank SVP, Clinical R&D, CMO 03/26/2012 7,170
Haluska Frank SVP, Clinical R&D, CMO 03/26/2012 48,000
Haluska Frank SVP, Clinical R&D, CMO 03/23/2012 102,718
Keane Raymond T SVP General Counsel & CCO 03/23/2012 162,271
DODION PIERRE F SVP, Corp. Dev. & Operations 03/23/2012 380,712
FITZGERALD EDWARD M Executive VP, CFO 03/23/2012 199,239
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/22/2012 162,178
BERGER HARVEY J M D Chairman & CEO 03/22/2012 639,368
CLACKSON TIMOTHY P President, R&D, CSO 03/23/2012 236,211
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/23/2012 162,274
BERGER HARVEY J M D Chairman & CEO 03/20/2012 157,092
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/20/2012 282,314
Keane Raymond T SVP General Counsel & CCO 03/20/2012 126,155
Haluska Frank SVP, Clinical R&D, CMO 03/20/2012 225,240
FITZGERALD EDWARD M Executive VP, CFO 03/20/2012 468,605
DODION PIERRE F SVP, Corp. Dev. & Operations 03/20/2012 194,799
CLACKSON TIMOTHY P President, R&D, CSO 03/20/2012 546,622
Cantor Maria E SVP, Corporate Affairs 03/20/2012 210,218
CLACKSON TIMOTHY P President, R&D, CSO 03/16/2012 62,192
BERGER HARVEY J M D Chairman & CEO 03/10/2012 998,660
LAMARCHE JAY R Director 02/28/2012 88,800
BERSTEIN DAVID L Senior VP, Chief IP Officer 02/28/2012 44,703
BERSTEIN DAVID L Senior VP, Chief IP Officer 02/28/2012 176,313
DODION PIERRE F SVP, Corp. Dev. & Operations 02/23/2012 137,250
DODION PIERRE F SVP, Corp. Dev. & Operations 02/23/2012 375,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 02/23/2012 61,500
Haluska Frank SVP, Clinical R&D, CMO 02/21/2012 10,755
Haluska Frank SVP, Clinical R&D, CMO 02/21/2012 65,277
BERSTEIN DAVID L Senior VP, Chief IP Officer 02/21/2012 88,920
BERSTEIN DAVID L Senior VP, Chief IP Officer 02/21/2012 509,032
BERGER HARVEY J M D Chairman & CEO 02/15/2012 344,826
CLACKSON TIMOTHY P President, R&D, CSO 02/14/2012 64,350
CLACKSON TIMOTHY P President, R&D, CSO 02/14/2012 255,750
CLACKSON TIMOTHY P President, R&D, CSO 02/14/2012 312,908
CLACKSON TIMOTHY P President, R&D, CSO 02/14/2012 1,155,781
Keane Raymond T SVP General Counsel & CCO 02/14/2012 16,250
Keane Raymond T SVP General Counsel & CCO 02/14/2012 189,178
LAMARCHE JAY R Director 01/27/2012 404,974
LAMARCHE JAY R Director 01/26/2012 46,627
BERGER HARVEY J M D Chairman & CEO 07/26/2011 100,018
CLACKSON TIMOTHY P President, R&D, CSO 06/07/2011 378,576
CLACKSON TIMOTHY P President, R&D, CSO 06/07/2011 339,000
BERSTEIN DAVID L Senior VP, Chief IP Officer 06/07/2011 381,854
BERSTEIN DAVID L Senior VP, Chief IP Officer 06/07/2011 339,000
LAMARCHE JAY R Director 05/09/2011 141,241
LAMARCHE JAY R Director 05/09/2011 141,250
DODION PIERRE F Senior VP, Corp. Development 04/11/2011 61,599
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 04/11/2011 123,190
CLACKSON TIMOTHY P President, R&D, CSO 04/11/2011 103,123
BERSTEIN DAVID L Senior VP, Chief IP Officer 04/11/2011 54,204
FITZGERALD EDWARD M Executive VP, CFO 04/11/2011 78,120
LAMARCHE JAY R Director 03/25/2011 175,277
Keane Raymond T SVP General Counsel & CCO 03/22/2011 54,660
Haluska Frank VP, Clinical R&D, CMO 03/22/2011 28,116
DODION PIERRE F Senior VP, Corp. Development 03/22/2011 42,276
CLACKSON TIMOTHY P President, R&D, CSO 03/22/2011 78,424
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 03/22/2011 66,769
BERSTEIN DAVID L Senior VP, Chief IP Officer 03/22/2011 54,373
LAMARCHE JAY R Director 02/02/2011 161,925
LAMARCHE JAY R Director 01/11/2011 137,675
LAMARCHE JAY R Director 01/11/2011 137,388
LAMARCHE JAY R Director 12/20/2010 125,006
Bollag Daniel M Sr. VP, Reg. Affairs & Quality 10/26/2010 11,100
CLACKSON TIMOTHY P Pres., R & D., Chief Sci. Off. 10/26/2010 37,000
Load More Insider Transactions